the 10ml vial supports multi-vial or volume-intensive research protocols
It simply means that the "first-line" screening didn't find a significant abnormality
GHK-Cu in research models has been reported to engage: MMP / TIMP expression in extracellular matrix studies Nrf2-mediated antioxidant gene expression TGF-beta signaling in fibroblast cultures Copper-dependent enzymes (such as lysyl oxidase) Broad gene expression changes observed via Connectivity Map analysis (Campbell et al., 2012) KPV in research models has been reported to engage: NF-kB transcription factor activation and nuclear translocation Pro-inflammatory cytokine output (TNF-alpha, IL-6, IL-1beta) Mast cell mediator release Intestinal epithelial inflammation markers via PepT1-mediated uptake (Dalmasso et al., 2008) The two pathway lists rarely intersect in the peer-reviewed literature
For guidance on the broader landscape of peptides used in metabolic and hormonal health, see Peptides for Insulin Resistance: GLP-1, Tesamorelin & Emerging Compounds
[31] Other than anemia, hematological symptoms may include cytopenias, intramedullary hemolysis, and pseudothrombotic microangiopathy
Please check out the resources below to help answer all your questions